28 julio 2015
A non-steroidal anti-inflammatory drug (NSAID) called ketorolac helped women with ovarian cancer to survive longer, researchers report. Ketorolac, marketed as Toradol®, is approved for clinical use in the United States for pain after surgery.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/4fKUoZf3xUs» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/4fKUoZf3xUs/150728123717.htm
